Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12086757rdf:typepubmed:Citationlld:pubmed
pubmed-article:12086757lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:12086757lifeskim:mentionsumls-concept:C0302600lld:lifeskim
pubmed-article:12086757lifeskim:mentionsumls-concept:C0021775lld:lifeskim
pubmed-article:12086757lifeskim:mentionsumls-concept:C1522505lld:lifeskim
pubmed-article:12086757lifeskim:mentionsumls-concept:C0302350lld:lifeskim
pubmed-article:12086757lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:12086757pubmed:issue9323lld:pubmed
pubmed-article:12086757pubmed:dateCreated2002-6-27lld:pubmed
pubmed-article:12086757pubmed:abstractTextRecombinant fibroblast growth factor-2 (rFGF-2) improves perfusion in models of myocardial and hindlimb ischaemia. We investigated whether one or two doses of intra-arterial rFGF-2 improves exercise capacity in patients with moderate-to-severe intermittent claudication.lld:pubmed
pubmed-article:12086757pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12086757pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12086757pubmed:languageenglld:pubmed
pubmed-article:12086757pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12086757pubmed:citationSubsetAIMlld:pubmed
pubmed-article:12086757pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12086757pubmed:statusMEDLINElld:pubmed
pubmed-article:12086757pubmed:monthJunlld:pubmed
pubmed-article:12086757pubmed:issn0140-6736lld:pubmed
pubmed-article:12086757pubmed:authorpubmed-author:WhitehouseM...lld:pubmed
pubmed-article:12086757pubmed:authorpubmed-author:AnnexBrian...lld:pubmed
pubmed-article:12086757pubmed:authorpubmed-author:LedermanRober...lld:pubmed
pubmed-article:12086757pubmed:authorpubmed-author:MendelsohnFar...lld:pubmed
pubmed-article:12086757pubmed:authorpubmed-author:AndersonR...lld:pubmed
pubmed-article:12086757pubmed:authorpubmed-author:SaucedoJorge...lld:pubmed
pubmed-article:12086757pubmed:authorpubmed-author:TenagliaAlan...lld:pubmed
pubmed-article:12086757pubmed:authorpubmed-author:HermillerJame...lld:pubmed
pubmed-article:12086757pubmed:authorpubmed-author:HillegassWill...lld:pubmed
pubmed-article:12086757pubmed:authorpubmed-author:Rocha-SinghKr...lld:pubmed
pubmed-article:12086757pubmed:authorpubmed-author:MoonThomas...lld:pubmed
pubmed-article:12086757pubmed:authorpubmed-author:TRAFFIC...lld:pubmed
pubmed-article:12086757pubmed:issnTypePrintlld:pubmed
pubmed-article:12086757pubmed:day15lld:pubmed
pubmed-article:12086757pubmed:volume359lld:pubmed
pubmed-article:12086757pubmed:ownerNLMlld:pubmed
pubmed-article:12086757pubmed:authorsCompleteYlld:pubmed
pubmed-article:12086757pubmed:pagination2053-8lld:pubmed
pubmed-article:12086757pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12086757pubmed:meshHeadingpubmed-meshheading:12086757...lld:pubmed
pubmed-article:12086757pubmed:meshHeadingpubmed-meshheading:12086757...lld:pubmed
pubmed-article:12086757pubmed:meshHeadingpubmed-meshheading:12086757...lld:pubmed
pubmed-article:12086757pubmed:meshHeadingpubmed-meshheading:12086757...lld:pubmed
pubmed-article:12086757pubmed:meshHeadingpubmed-meshheading:12086757...lld:pubmed
pubmed-article:12086757pubmed:meshHeadingpubmed-meshheading:12086757...lld:pubmed
pubmed-article:12086757pubmed:meshHeadingpubmed-meshheading:12086757...lld:pubmed
pubmed-article:12086757pubmed:meshHeadingpubmed-meshheading:12086757...lld:pubmed
pubmed-article:12086757pubmed:meshHeadingpubmed-meshheading:12086757...lld:pubmed
pubmed-article:12086757pubmed:meshHeadingpubmed-meshheading:12086757...lld:pubmed
pubmed-article:12086757pubmed:meshHeadingpubmed-meshheading:12086757...lld:pubmed
pubmed-article:12086757pubmed:meshHeadingpubmed-meshheading:12086757...lld:pubmed
pubmed-article:12086757pubmed:meshHeadingpubmed-meshheading:12086757...lld:pubmed
pubmed-article:12086757pubmed:meshHeadingpubmed-meshheading:12086757...lld:pubmed
pubmed-article:12086757pubmed:year2002lld:pubmed
pubmed-article:12086757pubmed:articleTitleTherapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial.lld:pubmed
pubmed-article:12086757pubmed:affiliationDivision of Cardiology, University of Michigan Health System, Ann Arbor, MI, USA. lederman@nih.govlld:pubmed
pubmed-article:12086757pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12086757pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:12086757pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:12086757pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12086757lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12086757lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12086757lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12086757lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12086757lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12086757lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12086757lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12086757lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12086757lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12086757lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12086757lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12086757lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12086757lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12086757lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12086757lld:pubmed